-
CNSP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
CNS Pharmaceuticals (CNSP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 6.97 mm | 6.97 mm | 6.97 mm | 6.97 mm | 6.97 mm | 6.97 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.88 mm | 1.51 mm | 2.27 mm | 1.06 mm |
Cash used (since last report) | n/a | n/a | 5.28 mm | 4.24 mm | 6.38 mm | 2.98 mm |
Cash remaining | n/a | n/a | 1.69 mm | 2.73 mm | 590.13 k | 3.99 mm |
Runway (months of cash) | n/a | n/a | 0.9 | 1.8 | 0.3 | 3.8 |
13F holders | Current |
---|---|
Total holders | 3 |
Opened positions | 1 |
Closed positions | 13 |
Increased positions | 0 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 8.00 k |
Total shares | 5.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MS Morgan Stanley | 2.00 | $3.00 k |
Global Retirement Partners | 2.00 | $3.00 k |
BAC Bank of America | 1.00 | $2.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Apr 24 | Christopher Downs | RSU Common Stock | Grant | Acquire A | No | No | 0 | 40,000 | 0.00 | 241.572 |
8 Apr 24 | Christopher Downs | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.2586 | 40,000 | 10.34 k | 201.572 |
8 Apr 24 | Climaco John M | RSU Common Stock | Grant | Acquire A | No | No | 0 | 83,000 | 0.00 | 559,533 |
8 Apr 24 | Climaco John M | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.2586 | 83,000 | 21.46 k | 476,533 |
8 Apr 24 | Evans Carl Anthony | RSU Common Stock | Grant | Acquire A | No | No | 0 | 17,500 | 0.00 | 147,094 |
8 Apr 24 | Evans Carl Anthony | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.2586 | 17,500 | 4.53 k | 129,594 |
8 Apr 24 | Bettina M. Cockroft | RSU Common Stock | Grant | Acquire A | No | No | 0 | 17,500 | 0.00 | 53,074 |
8 Apr 24 | Bettina M. Cockroft | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.2586 | 17,500 | 4.53 k | 35,574 |
8 Apr 24 | Gumulka Jerzy | RSU Common Stock | Grant | Acquire A | No | No | 0 | 17,500 | 0.00 | 147,594 |
8 Apr 24 | Gumulka Jerzy | Option to purchase common stock Common Stock | Grant | Acquire A | No | No | 0.2586 | 17,500 | 4.53 k | 129,594 |